Palouse Capital Management, Inc. Merck & Co., Inc. Transaction History

Palouse Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$83.49 - $94.64 $3.3 Million - $3.74 Million	-39,517 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $4,116 - $4,614	56 Added 0.14%	39,517 $3.24 Million
Q4 2021 Jan 25, 2022	SELL	$72.28 - $90.54 $49,511 - $62,019	-685 Reduced 1.71%	39,461 $3.02 Million
Q3 2021 Oct 21, 2021	SELL	$71.68 - $78.83 $2.95 Million - $3.25 Million	-41,198 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $310,348 - $343,276	4,414 Added 12.0%	41,198 $3.2 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $2.53 Million - $2.98 Million	36,784 New	36,784 $2.84 Million

3,826

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Palouse Capital Management, Inc. with notifications on news.